This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Washington University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations by Tyler Ulland in Neurodegenerative Disease Treatment.
Introduction
Tyler Ulland is an innovative inventor based in St. Louis, MO (US). He has made significant contributions to the field of neurodegenerative diseases through his research and patent work. His focus on microglial dysfunction has the potential to impact the treatment of various neurodegenerative conditions.
Latest Patents
Tyler Ulland holds a patent for "Methods for treating microglial dysfunction." This patent outlines methods for treating diseases, disorders, and conditions associated with microglial dysfunction. The disclosure provides a method for treating microglial dysfunction in subjects with neurodegenerative diseases by administering a therapeutically effective amount of a microglial rescuing agent. Additionally, it describes a method for reversing neuronal damage in subjects with such diseases, particularly those characterized by single nucleotide polymorphisms (SNPs) or mutations in Trem2 or ApoE that affect microglial functions. He has 1 patent to his name.
Career Highlights
Tyler Ulland is affiliated with Washington University, where he conducts his research. His work is pivotal in understanding the mechanisms of neurodegenerative diseases and developing potential therapeutic strategies.
Collaborations
Tyler collaborates with Marco Colonna, a notable figure in the field, to advance research on microglial functions and their implications in neurodegenerative diseases.
Conclusion
Tyler Ulland's innovative work in treating microglial dysfunction represents a significant advancement in neurodegenerative disease research. His contributions have the potential to lead to new therapeutic approaches that could improve the lives of many individuals affected by these conditions.